Clinical Trial to Evaluate the Tolerability & the Pharmacokinetics of

Updated 06/21/2024

Status Completed

Clinical Trial Summary

A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05549401
Study type	Interventional
Source	Chong Kun Dang Pharmaceutical
Contact
Status	Completed
Phase	Phase 1
Start date	September 29, 2022
Completion date	December 9, 2022

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05552495` - Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions	Phase 1
	Completed	`NCT04987970` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg	Phase 1
	Completed	`NCT04587206` - A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348	Phase 1
	Completed	`NCT02933658` - Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers	Phase 1
	Completed	`NCT05335044` - Study to Evaluate the Safety and Pharmacokinetics of CKD-331	Phase 1
	Completed	`NCT05245084` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg	Phase 1
	Completed	`NCT04883658` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)	Phase 1
	Completed	`NCT05698043` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg	Phase 1
	Completed	`NCT04660370` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348	Phase 1
	Completed	`NCT04673864` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386	Phase 1
	Completed	`NCT05192356` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)	Phase 1
	Completed	`NCT04694989` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)	Phase 1
	Completed	`NCT05749861` - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)	Phase 1
	Completed	`NCT04554953` - A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia